A Dose-Escalation Study to Evaluate Safety, Tolerability and Pharmacokinetics of Single Doses of Q203 in Normal, Healthy, Male and Female Volunteers
Clinical trial NCT02530710 · COMPLETED
Trial details
- NCT number
- NCT02530710
- Sponsor
- Qurient Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2016-01-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.